Gilbert HN - Search Results

1

Phase 1b/2a Study Assessing the Safety and Efficacy of Felzartamab in Anti-Phospholipase A2 Receptor Autoantibody-Positive Primary Membranous Nephropathy.

Rovin BH, Ronco PM, Wetzels JFM, Adler SG, Ayoub I, Zaoui P, Han SH, Dudani JS, Gilbert HN, Patel UD, Manser PT, Jauch-Lembach J, Faulhaber N, Boxhammer R, Härtle S, Sprangers B. Rovin BH, et al. Among authors: gilbert hn. Kidney Int Rep. 2024 Jun 20;9(9):2635-2647. doi: 10.1016/j.ekir.2024.06.018. eCollection 2024 Sep. Kidney Int Rep. 2024. PMID: 39291206 Free PMC article.

2

Patient-reported outcomes of adverse events after COVID-19 vaccination in Nigeria: A mixed methods study.

Ogar CK, Gilbert HN, Bloem LT, Leopold C, Bassi PU, Katagum YM, Osakwe AI, Opadeyi AO, Oreagba I, Mbo DND, Mantel-Teeuwisse AK, De Bruin ML. Ogar CK, et al. Among authors: gilbert hn. Vaccine. 2024 Oct 3;42(23):126196. doi: 10.1016/j.vaccine.2024.126196. Epub 2024 Aug 22. Vaccine. 2024. PMID: 39178765

3

A Randomized Phase 2 Trial of Felzartamab in Antibody-Mediated Rejection.

Mayer KA, Schrezenmeier E, Diebold M, Halloran PF, Schatzl M, Schranz S, Haindl S, Kasbohm S, Kainz A, Eskandary F, Doberer K, Patel UD, Dudani JS, Regele H, Kozakowski N, Kläger J, Boxhammer R, Amann K, Puchhammer-Stöckl E, Vietzen H, Beck J, Schütz E, Akifova A, Firbas C, Gilbert HN, Osmanodja B, Halleck F, Jilma B, Budde K, Böhmig GA. Mayer KA, et al. Among authors: gilbert hn. N Engl J Med. 2024 Jul 11;391(2):122-132. doi: 10.1056/NEJMoa2400763. Epub 2024 May 25. N Engl J Med. 2024. PMID: 38804514 Clinical Trial.

4

Exploring the Role of the Private Sector in Tuberculosis Detection and Management in Lima, Peru: A Mixed-Methods Patient Pathway Analysis.

Wippel C, Farroñay S, Gilbert HN, Millones AK, Acosta D, Torres I, Jimenez J, Alarcón VA, Lecca L, Yuen CM. Wippel C, et al. Among authors: gilbert hn. Am J Trop Med Hyg. 2024 May 14;111(1):168-175. doi: 10.4269/ajtmh.23-0504. Print 2024 Jul 3. Am J Trop Med Hyg. 2024. PMID: 38744270 Free PMC article.

5

A biosocial analysis of perinatal and late neonatal mortality among Indigenous Maya Kaqchikel communities in Tecpán, Guatemala: a mixed-methods study.

Venzor Strader A, Sotz M, Gilbert HN, Miller AC, Lee AC, Rohloff P. Venzor Strader A, et al. Among authors: gilbert hn. BMJ Glob Health. 2024 Apr 17;9(4):e013940. doi: 10.1136/bmjgh-2023-013940. BMJ Glob Health. 2024. PMID: 38631704 Free PMC article.

6

Non-communicable disease care in Sierra Leone: a mixed-methods study of the drivers and barriers to retention in care for hypertension.

Dibba Y, Kachimanga C, Gassimu J, Kulinkina AV, Bukhman G, Gilbert HN, Adler AJ, Mukherjee JS. Dibba Y, et al. Among authors: gilbert hn. BMJ Open. 2024 Feb 12;14(2):e077326. doi: 10.1136/bmjopen-2023-077326. BMJ Open. 2024. PMID: 38346892 Free PMC article.

7

Exploring the role of the private sector in tuberculosis detection and management in Lima, Peru: a mixed-methods patient pathway analysis.

Wippel C, Farroñay S, Gilbert HN, Millones AK, Acosta D, Torres I, Jimenez J, Lecca L, Yuen CM. Wippel C, et al. Among authors: gilbert hn. medRxiv [Preprint]. 2023 Sep 29:2023.09.27.23296252. doi: 10.1101/2023.09.27.23296252. medRxiv. 2023. Update in: Am J Trop Med Hyg. 2024 May 14;111(1):168-175. doi: 10.4269/ajtmh.23-0504. PMID: 37808756 Free PMC article. Updated. Preprint.

8

Understanding barriers to tuberculosis diagnosis and treatment completion in a low-resource setting: A mixed-methods study in the Kingdom of Lesotho.

Andom AT, Gilbert HN, Ndayizigiye M, Mukherjee JS, Lively CT, Nthunya J, Marole TA, Ratsiu M, Smith Fawzi MC, Yuen CM. Andom AT, et al. Among authors: gilbert hn. PLoS One. 2023 May 11;18(5):e0285774. doi: 10.1371/journal.pone.0285774. eCollection 2023. PLoS One. 2023. PMID: 37167298 Free PMC article.

9

Understanding reasons for suboptimal tuberculosis screening in a low-resource setting: A mixed-methods study in the Kingdom of Lesotho.

Andom AT, Gilbert HN, Ndayizigiye M, Mukherjee JS, Nthunya J, Marole TA, Smith Fawzi MC, Yuen CM. Andom AT, et al. Among authors: gilbert hn. PLOS Glob Public Health. 2022 Mar 16;2(3):e0000249. doi: 10.1371/journal.pgph.0000249. eCollection 2022. PLOS Glob Public Health. 2022. PMID: 36962295 Free PMC article.

10

Adverse Events to SARS-CoV-2 (COVID-19) Vaccines and Policy Considerations that Inform the Funding of Safety Surveillance in Low- and Middle-Income Countries: A Mixed Methods Study.

Ogar CK, Quick J, Gilbert HN, Vreman RA, Mantel-Teeuwisse AK, Mugunga JC. Ogar CK, et al. Among authors: gilbert hn. Drug Saf. 2023 Apr;46(4):357-370. doi: 10.1007/s40264-023-01279-3. Epub 2023 Feb 22. Drug Saf. 2023. PMID: 36811813 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

25 results

Search Page